On September 21, 2025, Athos Therapeutics unveiled Athos Omics AI, an AI-driven analytics platform that enables pharmaceutical, food, and cosmetic scientists to perform "micro-analytics" on omics data without programming. The platform simplifies the steps of pattern mining and gene relationships, accelerating the discovery of biomarkers and drug targets at a lower cost. For non-technical users, this provides visual tools to quickly answer complex questions. Future Impact: Democratize bioinformatics analysis, accelerate preclinical innovation and develop testable hypotheses at a higher speed.